Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

XKON/217950 stock hub

XKON/217950 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

XKON/217950is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
146.3B
Korea New Exchange
Market data

Live price

Current market quote for this ticker.

Current price
XKON/217950
In the news

Latest news · XKON/217950

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROICn/a
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All XKON/217950 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
130
Groups with data
10
Currency
KRW
Showing 130 of 130 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

13
MetricValue
Country
South Korea
Country code
KR
Exchange
Korea New Exchange
Financial currency
KRW
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
KRW 146.3B
Price
KRW 35,000
Price currency
KRW
Sic
2834
Symbol
xkon/217950
Website
https://pr-bio.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

4
MetricValue
Earnings Yield
-0.6%
FCF yield
-0.28%
P/B ratio
-173.33x
P/S ratio
821.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

5
MetricValue
Gross margin
90.55%
Gross Profit
KRW 161.4M
Net Income
KRW -883.5M
Pretax Margin
-495.83%
ROCE
-162

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

4
MetricValue
Cagr1y
-20.47%
Cagr3y
20.52%
Cagr5y
12.07%
Revenue Growth
-44.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

16
MetricValue
Assets
KRW 515.5M
Cash
KRW 429M
Current Assets
KRW 431.6M
Current Liabilities
KRW 46.5M
Debt
KRW 1B
Debt FCF
KRW -2.51
Equity
KRW -844.2M
Interest Coverage
-6.18
Liabilities
KRW 1.4B
Long Term Assets
KRW 83.8M
Long Term Liabilities
KRW 1.3B
Net Cash
KRW -614.2M
Net Cash By Market Cap
KRW -0.42
Tangible Book Value
KRW -844.2M
Tangible Book Value Per Share
KRW -21,105
WACC
7.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
9.28
Net Working Capital
KRW -27.4M
Quick ratio
9.23
Working Capital
KRW 385.1M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
-20.45%
200-day SMA
33,181.5
3Y total return
75.09%
50-day SMA
33,138
50-day SMA vs 200-day SMA
50under200
5Y total return
76.77%
All Time High
50,000
All Time High Change
-30%
All Time High Date
2025-05-02
All Time Low
6,170
All Time Low Change
467.26%
All Time Low Date
2019-10-07
ATR
1,427.1
Beta
0.5
Beta1y
0.34
Beta2y
0.21
Ch YTD
10.76
High
35,500
High52
48,050
High52 Date
2025-05-20
High52ch
-27.16%
Low
34,000
Low52
25,000
Low52 Date
2025-12-12
Low52ch
40%
Ma50ch
5.62%
Price vs 200-day SMA
5.48%
RSI
53.5
RSI Monthly
53.22
RSI Weekly
55.61
Sharpe ratio
-0.03x
Sortino ratio
0.1
Tr YTD
10.76
Tr1m
9.38%
Tr1w
-3.58%
Tr3m
1.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
KRW -759.8M
Operating margin
-426.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

4
MetricValue
Float
1,892,076%
Net Borrowing
-50,666,654
Shares Insiders
8.78%
Shares Out
4,180,736

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

42
MetricValue
Adjusted FCF
KRW -415.8M
Average Volume
2,063.85x
Bv Per Share
-21,104.7
CAPEX
KRW -29.1M
Ch1m
9.38
Ch1w
-3.58
Ch1y
-20.45
Ch3m
1.6
Ch3y
75.09
Ch5y
76.77
Ch6m
21.11
Change
-0.85%
Change From Open
-1.41
Close
35,300
Days Gap
0.57
Depreciation Amortization
4,687,999
Dollar Volume
89,040,000
EBIT
KRW -759.8M
EBITDA
KRW -755.1M
EPS
KRW -22,088
F Score
1
FCF
KRW -415.8M
FCF Per Share
KRW -99.44
Financing CF
-50,666,654
Fiscal Year End
December
Founded
2,009
Investing CF
-71,762,649
Is Primary Listing
1
Ma150
32,341
Ma150ch
8.22%
Ma20
34,682.5
Ma20ch
0.92%
Net CF
-509,083,873
Open
35,500
Position In Range
66.67
Ppne
30,848,000
Price Date
2026-05-08
Relative Volume
1.23x
Revenue
178,189,289x
Tr6m
21.11%
Volume
2,544
Z Score
-6.67
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does XKON/217950 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/217950 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-20.5%
S&P 500 1Y: n/a
3Y total return
+75.1%
S&P 500 3Y: n/a
5Y total return
+76.8%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns XKON/217950?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+8.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

XKON/217950 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
53.5
Neutral momentum band
Price vs 200-day MA
+5.5%
50/200-day relationship not available
Beta (5Y)
0.50
Less volatile than the market
Sharpe ratio
-0.03
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About XKON/217950

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/217950 stock rating?

xkon/217950 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/217950 analysis?

The full report lives at /stocks/xkon/217950/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/217950?

The latest report frames xkon/217950 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/217950 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.